These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23587082)

  • 1. Commentary on Kaye et al. (2013): Attention deficit disorder in substance use disorder-a hidden or a conspicuous comorbidity? What does it change for patients?
    Garcia FD
    Addiction; 2013 May; 108(5):932-3. PubMed ID: 23587082
    [No Abstract]   [Full Text] [Related]  

  • 2. Attention deficit hyperactivity disorder and substance use disorders.
    Bukstein OG
    Curr Top Behav Neurosci; 2012; 9():145-72. PubMed ID: 21789746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attention deficit hyperactivity disorder and substance use disorders.
    Szobot CM; Bukstein O
    Child Adolesc Psychiatr Clin N Am; 2008 Apr; 17(2):309-23, viii. PubMed ID: 18295148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.
    Faraone SV; Wilens TE
    J Clin Psychiatry; 2007; 68 Suppl 11():15-22. PubMed ID: 18307377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does stimulant treatment lead to substance use disorders?
    Faraone SV; Wilens T
    J Clin Psychiatry; 2003; 64 Suppl 11():9-13. PubMed ID: 14529324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHD.
    Biederman J
    J Clin Psychiatry; 2003; 64 Suppl 11():3-8. PubMed ID: 14529323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical guidelines for the treatment of substance abusers with adult attention-deficit hyperactivity disorder.
    Levin FR; Evans SM; Kleber HD
    Psychiatr Serv; 1999 Aug; 50(8):1001-3. PubMed ID: 10445644
    [No Abstract]   [Full Text] [Related]  

  • 8. Attention-deficit/hyperactivity disorder treatment and later drug use.
    Furman L
    Pediatrics; 2003 Dec; 112(6 Pt 1):1459-60; author reply 1459-60. PubMed ID: 14654634
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety of stimulant treatment in attention deficit hyperactivity disorder: Part I.
    Merkel RL; Kuchibhatla A
    Expert Opin Drug Saf; 2009 Nov; 8(6):655-68. PubMed ID: 19785509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do stimulants prevent substance use and misuse among youth with attention-deficit/hyperactivity disorder? The answer is still maybe.
    Goldstein BI
    J Am Acad Child Adolesc Psychiatry; 2013 Mar; 52(3):225-7. PubMed ID: 23452678
    [No Abstract]   [Full Text] [Related]  

  • 11. Attention deficit hyperactivity disorder (ADHD) among illicit psychostimulant users: a hidden disorder?
    Kaye S; Darke S; Torok M
    Addiction; 2013 May; 108(5):923-31. PubMed ID: 23227816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood stimulant treatment and risk for later substance abuse.
    Fischer M; Barkley RA
    J Clin Psychiatry; 2003; 64 Suppl 11():19-23. PubMed ID: 14529326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.
    Upadhyaya HP
    J Clin Psychiatry; 2007; 68 Suppl 11():23-30. PubMed ID: 18307378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attention-deficit hyperactivity disorder diagnosis and treatment. Separating myth from substance.
    Barzman DH; Fieler L; Sallee FR
    J Leg Med; 2004 Mar; 25(1):23-38. PubMed ID: 15208788
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents.
    Wilens TE; Adamson J; Monuteaux MC; Faraone SV; Schillinger M; Westerberg D; Biederman J
    Arch Pediatr Adolesc Med; 2008 Oct; 162(10):916-21. PubMed ID: 18838643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptoms of ADHD or marijuana use?
    Graham NA; DuPont RL; Gold MS
    Am J Psychiatry; 2007 Jun; 164(6):973; author reply 973-4. PubMed ID: 17541060
    [No Abstract]   [Full Text] [Related]  

  • 17. Stimulant treatment for ADHD may not increase risk of substance abuse.
    Harv Ment Health Lett; 2008 Jun; 24(12):7. PubMed ID: 18946888
    [No Abstract]   [Full Text] [Related]  

  • 18. International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder.
    Crunelle CL; van den Brink W; Moggi F; Konstenius M; Franck J; Levin FR; van de Glind G; Demetrovics Z; Coetzee C; Luderer M; Schellekens A; ; Matthys F
    Eur Addict Res; 2018; 24(1):43-51. PubMed ID: 29510390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of comorbid substance use disorder during long-term central stimulant treatment in adult ADHD.
    Torgersen T; Gjervan B; Rasmussen K; Vaaler A; Nordahl HM
    Atten Defic Hyperact Disord; 2013 Mar; 5(1):59-67. PubMed ID: 23104523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing ADHD in the presence of comorbid substance use disorder.
    Upadhyaya HP
    J Clin Psychiatry; 2007 Jun; 68(6):e15. PubMed ID: 17592902
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.